PUBLISHER: Grand View Research | PRODUCT CODE: 1679571
PUBLISHER: Grand View Research | PRODUCT CODE: 1679571
The global anti-counterfeit pharmaceutical and cosmetic packaging market size is anticipated to reach USD 168.08 billion by 2030, registering a CAGR of 8.65% during the forecast period, according to a new report by Grand View Research, Inc. The industry is a crucial segment within the global packaging and security industry, driven by the increasing need for product authenticity, consumer safety, and brand protection. Counterfeit drugs and cosmetics pose significant health risks and financial losses, prompting manufacturers to adopt advanced security measures in their packaging solutions. Anti-counterfeit packaging technologies, including tamper-evident seals, track-and-trace systems, holographic labels, and digital authentication methods, are now essential components of modern packaging strategies. These solutions help ensure supply chain integrity while complying with stringent global regulations aimed at preventing the circulation of counterfeit products.
One of the key growth drivers for this market is the rising regulatory enforcement across pharmaceutical and cosmetic sectors. Governments worldwide have introduced strict mandates, such as the U.S. Drug Supply Chain Security Act (DSCSA) and the European Falsified Medicines Directive (FMD), requiring serialization and verification technologies to enhance transparency in supply chains. Similarly, luxury cosmetic brands are increasingly investing in smart packaging technologies-such as NFC-enabled verification and blockchain-based authentication-to safeguard their premium products against counterfeiting. Additionally, the rapid expansion of e-commerce and cross-border trade has heightened the demand for secure packaging solutions that allow real-time product verification and tracking, further driving innovation and investment in anti-counterfeit packaging technologies.
The market players are focusing on various strategic initiatives such as mergers, acquisitions, and collaborations. For instance, in January 2025, ALPLA, a global packaging and recycling specialist, fully integrated its Egyptian site by acquiring all shares from its joint venture partner, Taba, on December 16, 2024. The acquisition finalized ALPLA's control of the facility in 10th of Ramadan City near Cairo, which manufactures plastic bottles, preforms, and closures for North African and Middle Eastern markets. The site also became the central accounting service hub for the Africa, Middle East & Turkey (AMET) region in 2024. ALPLA's focus in Egypt includes producing standard and anti-counterfeit packaging for pharmaceutical products and processing post-consumer recycled material (PCR) to support the local circular economy.